Shares of Indivior PLC (LON:INDV – Get Free Report) hit a new 52-week high on Thursday . The stock traded as high as £1,453 ($1,794.71) and last traded at GBX 1,425 ($17.60), with a volume of 782614 shares. The stock had previously closed at GBX 1,514 ($18.70).
Indivior Stock Performance
The company has a market capitalization of £1.91 billion, a PE ratio of 140,800.00, a PEG ratio of -5.57 and a beta of -0.05. The company has a 50 day moving average of GBX 1,619.74 and a two-hundred day moving average of GBX 1,443.29. The company has a debt-to-equity ratio of 240.17, a current ratio of 0.97 and a quick ratio of 1.52.
Insider Transactions at Indivior
In other news, insider Mark Crossley sold 10,549 shares of the stock in a transaction on Monday, March 18th. The stock was sold at an average price of GBX 1,617 ($19.97), for a total value of £170,577.33 ($210,693.34). Insiders own 3.21% of the company’s stock.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Stocks Leading the U.S. Agriculture Comeback
- The 3 Best Retail Stocks to Shop for in August
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Market Cap Calculator: How to Calculate Market Cap
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
